from Reuters: Health News https://ift.tt/2OSUO3n
Takeda Pharmaceutical Co Ltd has proposed to European regulators it could sell a Shire treatment in development due to concerns of overlap in inflammatory bowel disease treatments and its own drug Entyvio as it seeks clearance for the two companies' merger.

from Reuters: Health News https://ift.tt/2OSUO3n
from Reuters: Health News https://ift.tt/2OSUO3n
No comments:
Post a Comment